109
Views
5
CrossRef citations to date
0
Altmetric
Research Article

The Distribution Kinetics of Topical 14C‐Sulfur Mustard in Rabbit Ocular Tissues and the Effect of Acetylcysteine

, , , , , , , , & show all
Pages 201-214 | Published online: 18 Nov 2003

References

  • Prentiss A M. Chemicals in War. A Treatise on Chemical War. McGraw‐Hill, New York 1937
  • Heller C E. Chemical Warfare in World War I: The American Experience, 1917–1918. Leavenworth Papers, Fort Leavenworth, KA, U.S.Army Command and General Staff College, Combat Studies Institute. 1984; Vol. 10, Ref. Type: Report
  • Dowen T E, Bellamy R F. Emergency War Surgery. U.S. Government Printing Office, Washington, D.C. 1998
  • Treister G. Ocular casualties in the Six‐Day War. Am J Ophthalmol 1969; 68: 669–673
  • Nagy S M, Golombic C, Stein W H. The penetration of vesicant vapors into human skin. Gen Physiol 1946; 29: 441–469
  • Safarinejad M R, Moosavi S A, Montazeri B. Ocular injuries caused by mustard gas: diagnosis, treatment and medical defense. Mil Med 2001; 166: 67–70
  • Kadar T, Turetz J, Fishbine E, Sahar R, Chapman S, Amir A. Characterization of acute and delayed ocular lesions induced by sulfur mustard in rabbits. Curr Eye Res 2001; 22: 42–53
  • Langenberg J P, van der Schaans G P, Spruit H ET, Kuijpers W C, Mars‐Groenendijk R H, van Dijk‐Knijnenburg H CM, Trap H C, van Helden H PM, Benschop H P. Toxicokinetics of sulfur mustard and its DNA‐adducts in the hairless guinea pig. Proc Med Def Biosci Rev 1998
  • Maisonneuve A, Callebat I, Debordes L, Coppet L. Distribution of [14C]sulfur mustard in rats after intravenous exposure. Toxicol Appl Pharmacol 1993; 125: 281–287
  • Chen H.‐B, Yamabayashi S, Ou B, Ohno S, Tsukahara S. Structure and composition of the precorneal tear film—a study by in vivo cryofixation. Investig Ophthalmol Vis Sci 1997; 38: 381–387
  • Pyrdal J I, Campbell F W. Study of precorneal tear film thickness and structure by interferometry and confocal microscopy. Investig Ophthalmol Vis Sci 1992; 33: 1996–2005
  • Thermes F, Molon‐Noblot S, Grove J. Effects of acetylcysteine on rabbit conjunctival and corneal surfaces—a scanning electron microscopy study. Investig Ophthalmol Vis Sci 1991; 32: 2958–2963
  • Anderton P, Tragoulias S. Mucous contribution to the rat‐tear film thickness measured with a microelectrode technique. Adv Exp Med Biol 1998; 438: 247–252
  • Fitton J H, Ziegelaar B W, Hicks C R, Clayton A B, Crawford G J, Constable I J, Chirila T V. Assessment of anticollagenase treatments after insertion of keratoprosthetic material in the rabbit cornea. Cornea 1998; 17: 108–114
  • Anderson D R, Byers S L, Vesely K R. Treatment of sulfur mustard induced lung injury. Proc Med Def Biosci Rev 1998
  • Walker I G, Smith J F. Protection of L‐cells by thiols against the toxicity of sulfur mustard. Can J Physiol Pharm 1969; 47: 143–151
  • Gross C L, Innace J K, Krebs R C, Smith W J, Meier H L. Sulfur mustard (HD) cytotoxicity in lymphocytes can be affected by intracellular glutathione levels. FASEB J 1989; 3: 583
  • Cowan F M, Broomfield C A, Smith W J. Inhibition of sulfur mustard‐increased protease activity by niacinamide, N‐acetyl‐L‐cysteine or dexamethasone. Cell Biol Toxicol 1992; 8: 129–138
  • Gross C L, Innace J K, Hovatter R C, Meier H L, Smith W J. Biochemical manipulation of intracellular glutathione levels influences cytotoxicity of isolated human lymphocytes by sulfur mustard. Cell Biol Toxicol 1993; 9: 259–267
  • Wilde P E, Upshall D G. Cysteine esters protect cultured rodent lung slices from sulphur mustard. Human Exp Toxicol 1994; 13: 743–748
  • Smith C N, Lindsay C, Upshall D G. Presence of methenamine/glutathione mixtures reduces the cytotoxic effect of sulphur mustard on cultured SVK‐14 human keratinocytes in vitro. Human Exp Toxicol 1997; 16: 247–253
  • Gross C L, Giles K C, Smith W J. L‐oxothiazolidine 4‐carboxylate pretreatment of isolated human peripheral blood lymphocytes reduces sulfur mustard cytotoxicity. Cell Biol Toxicol 1997; 13: 167–173
  • Lindsay C D, Hambrook J L, Lailey A F. Monoisopropylglutathione ester protects A549 cells from the cytotoxic effects of sulphur mustard. Human Exp Toxicol 1997; 16: 636–644
  • Amir A, Chapman S, Gozes Y, Sahar R, Allon N. Protection by extracellular glutathione against sulfur mustard induced toxicity in vitro. Human Exp Toxicol 1998; 17: 652–660
  • Atkins K B, Lodhi I J, Hurley L L, Hinshaw D B. N‐acetyl‐cysteine (NAC) and endothelial cell injury by sulfur mustard. Proc Med Def Biosci Rev 1998
  • Amir A, Turetz J, Chapman S, Fishbein E, Meshulam J, Sahar R, Liani H, Gilat E, Kadar T. Beneficial effects of topical anti‐inflammatory drugs against sulfur mustard‐induced ocular lesions in rabbits. J Appl Toxicol 2000; 20: S109–S114
  • Anderson M E. Determination of glutathione and glutathione disulfide in biological samples. Methods in Enzymology, A Meister. Academic Press. 1985; Vol. 113: 548–555
  • Maisonneuve A, Callebat I, Debordes L, Coppet L. Biological fate of sulphur mustard in rat: toxicokinetics and disposition. Xenobiotica 1993; 23: 771–780
  • Kadar T, Amir A, Fishbein E, Chapman S, Liani H, Sahar R, Rabinowitz I, Simon G A, Frishman G, Sheivitz R, Turetz J. The potential therapy of steroids against ocular lesions induced by sulfur mustard in rabbits. Proc Med Def Biosci Rev 1996; II: 845–853, Baltimore, MD
  • Schoenwald R D. Ocular pharmacokinetics. Textbook of Ocular Pharmacology, T J Zimmerman, K S Kooner, M Sharir, R D Fechtner. Lippincot‐Raven Publishers, Philadelphia 1997; 119–138
  • Klain G J, Omaye S T, Schuschereba S T, Mckinney L M. Ocular toxicity of systemic and topical exposure to butyl 2‐chloroethyl sulfide. J Toxicol, Cutan Ocul Toxicol 1991; 10: 289–302
  • van der Schans G P, Noort D, Mars‐Groenendijk R H, Fidder A, Chau L F, de Jong l P, Benschop H P. Immunochemical detection of sulfur mustard adducts with keratins in the stratum corneum of human skin. Chem Res Toxicol 2002; 15(1)21–25
  • Chapman S, Kadar T, Allon N, Gozes Y, Amir A. Differential response of corneal epithelial and macrophage cell lines to sulfur mustard: effects of anti‐inflammatory drug treatments. Proc Med Def Biosci Rev 2000; 1014–1023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.